Gynecology and Obstetrics

Your Gift Makes a Difference

你的捐赠可以帮助现在和将来的推荐十大正规网赌平台，因为我们期待先进的医学, treatments and new discoveries.

像您这样的捐赠者的支持帮助约翰霍普金斯大学开发了妇科癌症的新疗法和新方案, enhance labor and delivery methods, and perfect treatments for a range of reproductive conditions and diseases. Making a gift to Johns Hopkins is a vote of confidence. 我们非常感谢您与妇产科的合作，并高度评价您在推进约翰霍普金斯医学院的科学使命以造福患者方面的投资.

Support the Fertility Center March is Endometriosis Awareness Month

子宫内膜异位症是一种影响大约2%到10%的年龄在25到40岁之间的美国女性的疾病. It is also one of the most common conditions linked to female infertility. 有治疗子宫内膜异位症相关的疼痛和不孕的方法，但目前还没有治愈方法. Dr. 西格斯和他在霍普金斯大学西格·琼斯实验室的团队正在研究治疗子宫内膜异位症的新方法.

Support Gynecologic Cancer Prevention Finding Cures for Women's Cancers

约翰霍普金斯大学在以患者为中心的妇科癌症治疗方面处于领先地位. “腰带以下”的癌症需要复杂的治疗和具有卓越调查能力的研究团队, surgical and analytical skills. 您的支持帮助我们的医生专注于通过研究和创新来降低妇科癌症的死亡率.

Support Our Residents Fueling Research Innovation

Philanthropic support assists trainees during their residency training, through fellowships and during new appointments in developing research. 联邦研究奖励很难获得，并且需要初步数据才能被考虑. 支持妇产科校友会提供过桥资金，帮助学员和早期职业教师竞争更大的临床研究经费.

Support Community Partnerships The Violet Project

Supporting our community is central to the mission of Johns Hopkins Medicine. “紫罗兰项目”的诞生是为了增加社会弱势青少年和年轻人获得月经产品和生殖保健的机会. 您的支持将帮助紫罗兰项目维持其数字健康平台，并发展一个由青少年领袖组成的网络，他们在当地学校志愿担任倡导者和拥护者. 

Expanded Fertility Center Provides Comprehensive Care

The Johns Hopkins Fertility Center recently expanded, doubling the number of consult and ultrasound rooms, creating additional workspace for clinical and nonclinical employees, and adding a team room where doctors, nurse practitioners and medical assistants can discuss patient care. “我们在建立中心时考虑到了患者的体验，并以一种促进护理团队所有成员之间沟通的方式,” says Valerie Baker, 约翰霍普金斯大学生殖内分泌和不孕症中心主任.

‘Game-Changer’ Intervention for Ovarian Cancer Prevention

Ovarian cancer is a notoriously difficult group of diseases to diagnose and treat. 目前还没有有效的筛查方法——大多数人在开始出现症状时就已经有了广泛的转移性癌症, and most patients die within five years. Additionally, the most lethal type — high-grade serous carcinoma — is the most common, and is the fifth-most common cause of cancer-related death for women in the U.S. A new approach offers some hope in preventing this disease, which will affect 1 in 78, or 1% to 2%, of women in their lifetimes.